PFECongressional Stock Trades
Pfizer Inc.
Pharmaceutical Preparations
Congressional stock trades in Pfizer Inc. (PFE) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
29
Politicians Trading
15
Last Traded
Jul 7, 2026
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ro KhannaD | Aug 7, 2026 | Jul 7, 2026 | Buy | $1,001 - $15,000 | +14.91% |
| Gilbert Ray Cisneros, Jr.D | Mar 9, 2026 | Feb 10, 2026 | Buy | $1,001 - $15,000 | +0.18% |
| Gilbert Ray Cisneros, Jr.D | Jan 12, 2026 | Dec 19, 2025 | Sell | $1,001 - $15,000 | +9.81% |
| Gilbert Ray Cisneros, Jr.D | Dec 15, 2025 | Nov 18, 2025 | Buy | $1,001 - $15,000 | +8.68% |
| Gilbert Ray Cisneros, Jr.D | Sep 12, 2025 | Aug 5, 2025 | Sell | $1,001 - $15,000 | +11.76% |
| Josh GottheimerD | Jul 16, 2025 | Jun 3, 2025 | Sell | $1,001 - $15,000 | +18.46% |
| Gilbert Ray Cisneros, Jr.D | Jun 6, 2025 | May 30, 2025 | Buy | $1,001 - $15,000 | +17.75% |
| Gilbert Ray Cisneros, Jr.D | May 6, 2025 | Apr 29, 2025 | Buy | $1,001 - $15,000 | +16.27% |
| Gilbert Ray Cisneros, Jr.D | Apr 7, 2025 | Mar 31, 2025 | Sell | $15,001 - $50,000 | +9.16% |
| Julie JohnsonD | Mar 12, 2025 | Feb 12, 2025 | Sell | $1,001 - $15,000 | +8.60% |
| Gilbert Ray Cisneros, Jr.D | Mar 6, 2025 | Feb 26, 2025 | Buy | $1,001 - $15,000 | +4.69% |
| Julie JohnsonD | Feb 12, 2025 | Jan 15, 2025 | Sell | $1,001 - $15,000 | +5.49% |
| Gilbert Ray Cisneros, Jr.D | Feb 11, 2025 | Jan 24, 2025 | Sell | $1,001 - $15,000 | +6.02% |
Price History
About Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.